Genmab — December 2020
-
God morgen.
-
Janssen Announces Health Canada Approval of DARZALEX
* Combination Regimen for Newly Diagnosed, Transplant-Eligible Patients with Multiple Myeloma - VTd- CASSIOPEIA -https://finance.yahoo.com/finance/news/now-open-experience-sky-high-130500836.html -
Changes in Biologics Dosing May Help Keep Patients Safe From COVID-19 https://www.targetedonc.com/view/changes-in-biologics-dosing-may-help-keep-patients-safe-from-covid-19
-
-
God morgen.
-
Onsdagens danske avisuddrag med prisfest, ISS og vaccinepas
https://www.proinvestor.com/investornyt/670613/onsdagens-danske-avisuddrag-med-prisfest-iss-og-vaccinepas -
-
Summary points from expert feedback:
Preliminary efficacy for BCMA-directed bispecifics ranging from 60% to 80% looks very promising
Risk/benefit profiles not mature enough to identify distinguishing features but too soon to rule out Amgen’s AMG 701 based on early safety data
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind